AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Future of the London Stock Exchange
Sir John Bell says he's happy with Immunocore's decision to list in the US. But what would have happened if they had listed on the London Stock Exchange? He can't see a magic bullet to sorting this out, but there has to be some sort of middle ground.